Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 74

1.

Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine.

Meineke I, Freudenthaler S, Hofmann U, Schaeffeler E, Mikus G, Schwab M, Prange HW, Gleiter CH, Brockmöller J.

Br J Clin Pharmacol. 2002 Dec;54(6):592-603.

2.

Lesion development in Marburg's type of acute multiple sclerosis: from inflammation to demyelination.

Bitsch A, Wegener C, da Costa C, Bunkowski S, Reimers CD, Prange HW, Brück W.

Mult Scler. 1999 Jun;5(3):138-46.

PMID:
10408713
3.

Pharmacokinetic optimisation of the treatment of bacterial central nervous system infections.

Nau R, Sörgel F, Prange HW.

Clin Pharmacokinet. 1998 Sep;35(3):223-46. Review.

PMID:
9784935
4.

[Postanoxia coma and prognosis. Position paper version 1.0 of the Working Group for Neurologic Intensive Care].

Haupt WF, Prange HW, Janzen RW.

Anaesthesist. 1998 Aug;47(8):682-4. German. No abstract available.

PMID:
9770092
5.

Disposition and elimination of meropenem in cerebrospinal fluid of hydrocephalic patients with external ventriculostomy.

Nau R, Lassek C, Kinzig-Schippers M, Thiel A, Prange HW, Sörgel F.

Antimicrob Agents Chemother. 1998 Aug;42(8):2012-6.

6.

Beta-trace protein concentration in cerebrospinal fluid is decreased in patients with bacterial meningitis.

Tumani H, Reiber H, Nau R, Prange HW, Kauffmann K, Mäder M, Felgenhauer K.

Neurosci Lett. 1998 Feb 6;242(1):5-8.

PMID:
9509992
7.

[Embolic complications in bacterial endocarditis].

Schünemann S, Werner GS, Schulz R, Bitsch A, Prange HW, Kreuzer H.

Z Kardiol. 1997 Dec;86(12):1017-25. German.

PMID:
9499500
8.

Kinetics of piperacillin and tazobactam in ventricular cerebrospinal fluid of hydrocephalic patients.

Nau R, Kinzig-Schippers M, Sörgel F, Schinschke S, Rössing R, Müller C, Kolenda H, Prange HW.

Antimicrob Agents Chemother. 1997 May;41(5):987-91.

9.

Slow elimination of mannitol from human cerebrospinal fluid.

Nau R, Desel H, Lassek C, Thiel A, Schinschke S, Rössing R, Kolenda H, Prange HW.

Eur J Clin Pharmacol. 1997;53(3-4):271-4.

PMID:
9476044
10.

[Pharmacodynamics and pharmacokinetics of therapeutic osmoregulating agents in increased intracranial pressure].

Prange HW, Nau R.

Zentralbl Neurochir. 1997;58(3):127-33. Review. German. No abstract available.

PMID:
9446463
11.

Focal neurologic deficits in infective endocarditis and other septic diseases.

Bitsch A, Nau R, Hilgers RA, Verheggen R, Werner G, Prange HW.

Acta Neurol Scand. 1996 Oct;94(4):279-86.

PMID:
8937541
12.
13.

Anti-inflammatory treatment influences neuronal apoptotic cell death in the dentate gyrus in experimental pneumococcal meningitis.

Zysk G, Brück W, Gerber J, Brück Y, Prange HW, Nau R.

J Neuropathol Exp Neurol. 1996 Jun;55(6):722-8.

PMID:
8642398
14.

Cerebrospinal fluid ceftazidime kinetics in patients with external ventriculostomies.

Nau R, Prange HW, Kinzig M, Frank A, Dressel A, Scholz P, Kolenda H, Sörgel F.

Antimicrob Agents Chemother. 1996 Mar;40(3):763-6.

15.

Estimation of steady state antibiotic concentration in cerebrospinal fluid from single-dose kinetics.

Nau R, Prange HW.

Eur J Clin Pharmacol. 1996;49(5):407-9. Review.

PMID:
8866638
16.

Activity of fosfomycin in a rabbit model of experimental pneumococcal meningitis.

Nau R, Zysk G, Reinert RR, Mergeryan H, Eiffert H, Prange HW.

J Antimicrob Chemother. 1995 Dec;36(6):997-1004.

PMID:
8821598
17.

[Laboratory diagnosis of infections of the central nervous system].

Nau R, Prange HW.

Internist (Berl). 1995 Feb;36(2):158-61. Review. German. No abstract available.

PMID:
7737806
18.

Kinetics of ofloxacin and its metabolites in cerebrospinal fluid after a single intravenous infusion of 400 milligrams of ofloxacin.

Nau R, Kinzig M, Dreyhaupt T, Kolenda H, Sörgel F, Prange HW.

Antimicrob Agents Chemother. 1994 Aug;38(8):1849-53.

19.

[Life threatening embolism caused by central venous catheter fragments in psychiatric patients].

Nau R, Thiel A, Prange HW.

Nervenarzt. 1994 May;65(5):350-2. German.

PMID:
8052339
21.

[Intensive care treatment of psychiatric patients].

Thiel A, Nau R, Willers T, Rüther E, Prange HW.

Nervenarzt. 1994 Mar;65(3):183-90. German.

PMID:
8177359
22.

Neuron-specific enolase concentrations in blood as a prognostic parameter in cerebrovascular diseases.

Schaarschmidt H, Prange HW, Reiber H.

Stroke. 1994 Mar;25(3):558-65.

PMID:
8128507
23.

[Pathophysiology, therapy and prognosis of hypoxic-ischemic brain damage].

Prange HW.

Z Kardiol. 1994;83 Suppl 6:127-34. Review. German.

PMID:
7532344
24.

Netilmicin cerebrospinal fluid concentrations after an intravenous infusion of 400 mg in patients without meningeal inflammation.

Nau R, Scholz P, Sharifi S, Rohde S, Kolenda H, Prange HW.

J Antimicrob Chemother. 1993 Dec;32(6):893-6. No abstract available.

PMID:
8144430
25.

Iatrogenic epidural spinal abscess.

Bollensen E, Menck S, Buzanoski J, Prange HW.

Clin Investig. 1993 Oct;71(10):780-6.

PMID:
8305833
26.

Reactivity of locally produced CSF antibodies in patients with neurosyphilis against antigens of Treponema pallidum.

Bollensen E, Albrecht S, Beuche W, Mäder M, Prange HW.

J Neurol. 1993 Sep;240(8):471-4.

PMID:
8263552
27.

Pharmacokinetics of glycerol administered orally in healthy volunteers.

Sommer S, Nau R, Wieland E, Prange HW.

Arzneimittelforschung. 1993 Jul;43(7):744-7.

PMID:
8369006
28.

Passage of cefotaxime and ceftriaxone into cerebrospinal fluid of patients with uninflamed meninges.

Nau R, Prange HW, Muth P, Mahr G, Menck S, Kolenda H, Sörgel F.

Antimicrob Agents Chemother. 1993 Jul;37(7):1518-24.

30.

Pharmacokinetic quantification of the exchange of drugs between blood and cerebrospinal fluid in man.

Nau R, Zysk G, Thiel A, Prange HW.

Eur J Clin Pharmacol. 1993;45(5):469-75.

PMID:
8112378
31.

Oral administration of glycerol may not cause hemolysis.

Nau R, Sommer S, Prange HW, Wieland E.

Stroke. 1992 Oct;23(10):1533-4. No abstract available.

PMID:
1412592
32.

Low blood-to-cerebrospinal fluid passage of sorbitol after intravenous infusion.

Nau R, Dreyhaupt T, Kolenda H, Prange HW.

Stroke. 1992 Sep;23(9):1276-9.

PMID:
1519282
33.

Penetration of rifampicin into the cerebrospinal fluid of adults with uninflamed meninges.

Nau R, Prange HW, Menck S, Kolenda H, Visser K, Seydel JK.

J Antimicrob Chemother. 1992 Jun;29(6):719-24.

PMID:
1506352
34.

[Subarachnoid hemorrhage with pulmonary edema and electrocardiographic changes. The differential diagnosis of myocardial infarct].

Nau R, Scheidt P, Gonska BD, Prange HW.

Dtsch Med Wochenschr. 1992 Apr 24;117(17):658-62. German.

PMID:
1572249
35.

Temporary reversal of serum to cerebrospinal fluid glycerol concentration gradient after intravenous infusion of glycerol.

Nau R, Prins FJ, Kolenda H, Prange HW.

Eur J Clin Pharmacol. 1992;42(2):181-5.

PMID:
1618250
36.

Results of four technical investigations in fifty clinically brain dead patients.

Nau R, Prange HW, Klingelhöfer J, Kukowski B, Sander D, Tchorsch R, Rittmeyer K.

Intensive Care Med. 1992;18(2):82-8.

PMID:
1613203
37.

[Neuro-monitoring using visual evoked potentials in comatose neurologic intensive care patients].

Adler G, Bransi A, Prange HW.

EEG EMG Z Elektroenzephalogr Elektromyogr Verwandte Geb. 1991 Dec;22(4):254-8. German.

PMID:
1786788
38.

[An epidural spinal abscess as a lethal complication of peridural anesthesia].

Bollensen E, Prange HW.

Reg Anaesth. 1991 Dec;14(6):101-3. German.

PMID:
1780484
39.

Serum concentrations of glycerol with continuous or discontinuous intravenous administration.

Nau R, Prin FJ, Prange HW.

Stroke. 1991 May;22(5):693-4. No abstract available.

PMID:
2028503
40.

[An unnoticed dislocation of the dens axis in a patient with primary chronic polyarthritis undergoing intensive therapy].

Bollensen E, Schönle PW, Braun U, Prange HW.

Anaesthesist. 1991 May;40(5):294-7. German.

PMID:
1867371
41.

Early heparin therapy in patients with spontaneous intracerebral haemorrhage.

Boeer A, Voth E, Henze T, Prange HW.

J Neurol Neurosurg Psychiatry. 1991 May;54(5):466-7.

42.

Brainstem compression by basilar artery anomalies as visualized by MRI.

Bollensen E, Buzanoski JH, Prange HW.

J Neurol. 1991 Feb;238(1):49-50.

PMID:
2030374
43.

Complications of plasma exchange in patients with neurological diseases.

Henze T, Prange HW, Talartschik J, Rumpf KW.

Klin Wochenschr. 1990 Dec 4;68(23):1183-8.

44.

[Listeriosis of the central nervous system].

Nau R, Schuchardt V, Prange HW.

Fortschr Neurol Psychiatr. 1990 Nov;58(11):408-22. Review. German.

PMID:
2279727
45.

Penetration of ciprofloxacin into the cerebrospinal fluid of patients with uninflamed meninges.

Nau R, Prange HW, Martell J, Sharifi S, Kolenda H, Bircher J.

J Antimicrob Chemother. 1990 Jun;25(6):965-73.

PMID:
2370242
46.

Emergence of antibiotic-resistant bacteria during selective decontamination of the digestive tract.

Nau R, Rüchel R, Mergerian H, Wegener U, Winkelmann T, Prange HW.

J Antimicrob Chemother. 1990 May;25(5):881-3. No abstract available.

PMID:
2098004
47.

Polyradiculoneuritis following botulinum toxin therapy.

Haug BA, Dressler D, Prange HW.

J Neurol. 1990 Feb;237(1):62-3.

PMID:
2319270
48.

Meningoencephalitis with septic intracerebral infarction: a new feature of CNS listeriosis.

Nau R, Brück W, Bollensen E, Prange HW.

Scand J Infect Dis. 1990;22(1):101-3.

PMID:
2320957
49.

[Neurologic diseases in herpesvirus infections].

Prange HW.

Fortschr Med. 1989 Aug 30;107(25):529-32. Review. German.

PMID:
2553560
50.

[Central nervous system infection caused by Aspergillus fumigatus. A complication of immunosuppressive therapy in myasthenia gravis].

Nau R, Behrends T, Henze T, Prange HW.

Nervenarzt. 1989 Mar;60(3):178-80. German. No abstract available.

PMID:
2654676

Supplemental Content

Loading ...
Support Center